Porto-based PFx Biotech introduced at present that it has closed a €2.5 million Seed funding spherical to advance its precision fermentation platform for producing bioidentical human milk proteins – aiming to ship sustainable, non-GMO, and allergy-free dietary options for all life levels.
The spherical was led by Buenavista Fairness Companions alongside EIT Meals and Beta Capital. This coincides with a latest €2.5 million grant from the EIC Accelerator, which is able to enable PFx Biotech to additional scale up the manufacturing of Lactoferrin to pre-industrial ranges, set up its personal bespoke labs, and develop the crew.
“It is a defining second for PFx Biotech,” mentioned Ali Osman, Founder and CEO of PFx Biotech. “We’re proud to be backed by mission – aligned buyers to assist us unlock the potential of Lactoferrin in a extra sustainable diet mannequin. As we enter this new development stage, we’re actively exploring strategic collaborations throughout R&D, scale-up, and go-to-market alternatives.”
Based in 2022, PFx Biotech is growing an engineering biology platform to supply extremely bioactive human milk proteins by way of a scalable precision fermentation course of, to be used within the superior diet markets.
Their crew brings expertise in dairy proteins, fermentation, molecular biology, scale up and open innovation, rooted in sustainability.
PFx Biotech’s engineering biology-based platform for the large-scale manufacturing of purposeful substances, together with human milk proteins, could be formulated into shopper merchandise starting from toddler components, sports activities diet and aged diet merchandise.
Human milk proteins are the golden dietary and health-promoting proteins in adolescence diet. By producing extremely bioactive various human milk proteins, via precision fermentation, PFx is reportedly creating a brand new class of substances that can assist and enhance the immune system.
Past new technology toddler components, their non-allergenic, GMO-, dairy- and animal-free proteins are simply digestible and bioavailable, making them ideally suited for all populations, together with these with particular dietary wants, particularly aged and athletes.
“We consider PFx Biotech is likely one of the few corporations with the scientific depth, technical execution, and visionary management required to make precision fermentation commercially viable at scale,” mentioned Bibi Sattar Marques, Accomplice at Buenavista Fairness Companions. “This funding displays our conviction in biology-driven options to reshape the meals system and our confidence within the PFx crew to guide that change.”
At a time when precision fermentation is rising as a cornerstone expertise for sustainable, nutritious, and resilient meals methods, this twin achievement locations the PFx Biotech in a really perfect place to additional its developments on this area.
“We’re not solely pushed by the pressing want of taking critical steps in the direction of disrupting the present proteins manufacturing methods, but additionally captivated with our mission to positively affect the lifetime of thousands and thousands,” added PFx Biotech.
